In particular, antibodies directed against thrombin, PC, plasmin, and FXa have been evident in SLE and APS [15,31,32,33], which potentiate rather than inhibit thrombotic and procoagulant effects [15,16,34]. This evidence concerns the gene F10 and autoimmune polyendocrinopathy.